Search Result For: Ozempic microdosing

Date: 2025/05/05 - 23:00

Wegovy Reduced Inflammation, Scarring in People with Serious Liver Disease

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 drug resolved liver inflammation in nearly two-thirds of participants, twice the rate seen with placebo.

Date: 2025/04/29 - 23:00

Ozempic May Cause Cosmetic Side Effects Like Sagging Skin, Wrinkly Feet

"Ozempic feet" and "Ozempic mouth" are the latest reported cosmetic side effects from GLP-1 medications used for weight loss. Experts say wrinkles and sagging skin can result from rapid weight loss due to loss of fat and muscle mass in certain areas of the body.

black and white photo of older person's hands arranging domino tiles

Date: 2025/04/09 - 21:00

Diabetes drugs like Ozempic or Jardiance may slash Alzheimer's risk

Two common types of anti-diabetes medications — GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.

Bailey Fields and Todd Kennedy rely on compounded GLP-1 drugs for weight loss

Date: 2025/04/02 - 23:32

Compounded GLP-1s Helped Them Lose Weight, But New FDA Rule Could Block Access

The FDA's new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain affordable weight loss medications. Here, two people who've relied on compounded GLP-1 drugs share their stories.

Date: 2025/04/02 - 23:00

Compounded GLP-1s Helped Them Lose Weight, But New FDA Rule Could Block Access

Date: 2025/03/20 - 00:00

Compounding Pharmacies to Stop Making Ozempic, Zepound Knockoffs: What to Know

The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now that the GLP-1 drug shortage has ended. People who rely on compounded GLP-1s say they may not be able to afford brand-name versions, which are often not covered by insurance.

Date: 2025/03/17 - 15:01

Mounjaro can boost weight loss in people without diabetes

People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label treatment, according to a new study funded by pharmaceutical company Eli Lilly.

An illustration showcasing three mobile phones featuring Medical News Today articles on depression and mental health

Date: 2025/03/15 - 15:32

3 factors may lower depression risk, new evidence suggests

An orange a day, regular moderate-to-vigorous exercise, and GLP-1 drugs for diabetes treatment have all been linked to a lower risk of depression in recent studies.

person in white sweater holding GLP-1 drug syringe

Date: 2025/02/25 - 21:00

Which diabetes drugs are linked to the lowest depression risk?

Compared to other diabetes medications, GLP-1 drugs like Ozempic were associated with a lower risk for depression in a recent study.

Date: 2025/02/23 - 11:31

GLP-1 drugs may aid brain health, but do they bring other risks?

Some studies link GLP-1 drugs for diabetes with neuroprotective benefits but others say that some of these drugs may increase depression risk, a new review concludes.